RA CAPITAL MANAGEMENT, L.P. - 07 Nov 2025 Form 4 Insider Report for Evommune, Inc.

Role
Director, 10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol
EVMN on NYSE
Transactions as of
07 Nov 2025
Net transactions value
+$20,000,000
Form type
4
Filing time
12 Nov 2025, 16:26:30 UTC
Previous filing
05 Nov 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON /s/ Peter Kolchinsky, Manager of RA Capital Management, L.P. 12 Nov 2025 0001346824

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVMN Common Stock Conversion of derivative security +1,517,329 1,517,329 07 Nov 2025 See Footnotes F1, F2, F3
transaction EVMN Common Stock Conversion of derivative security +691,441 691,441 07 Nov 2025 See Footnotes F1, F2, F4
transaction EVMN Common Stock Purchase $18,513,536 +1,157,096 +76% $16.00 2,674,425 07 Nov 2025 See Footnotes F2, F3
transaction EVMN Common Stock Purchase $1,486,464 +92,904 +13% $16.00 784,345 07 Nov 2025 See Footnotes F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVMN Series C Preferred Stock Conversion of derivative security -12,924,620 -100% 0 07 Nov 2025 Common Stock 1,517,329 See Footnotes F1, F2, F3
transaction EVMN Series C Preferred Stock Conversion of derivative security -5,889,699 -100% 0 07 Nov 2025 Common Stock 691,441 See Footnotes F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series C Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-8.518 basis and had no expiration date.
F2 RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
F3 Held directly by the Fund.
F4 Held directly by the Nexus Fund III.

Remarks:

Dr. Derek DiRocco, a Partner of the Adviser, serves on the Issuer's board of directors.